InsidersTradesSigma
Zealand Pharma A/S: directors' dealings · Denmark · Finanstilsynet DK
DK:zealand-pharma-asDK0060257814DK·Finanstilsynet DKMcap 21.9Bn€Healthcare & Pharma
Explore the full management transaction log of Zealand Pharma A/S, a publicly traded company based in Denmark. Shares are quoted on DK DK, under the authority of Finanstilsynet DK. Operating in the Healthcare & Pharma sector, Zealand Pharma A/S has published 54 insider filings. Market capitalisation: €21.9bn. The latest transaction was reported on 22 April 2026 — Other. Among the most active insiders: Unknown. Every trade is openly available.
54
Insider Decl.
0
Thresholds
€286,102
4 ops.
Buy Volume
€6m
16 ops.
Sell Volume
Financial data
310.60 €
Analyst consensus
15 analystsBuy
275.00 €Target 519.07 €(+67%)825.00 €
Valuation
PER (trailing)3.5x
PER (forward)38.4x
P/Book1.5x
Beta0.56
Balance sheet & cash
Market cap21.93 Bn€
Debt / Equity3%
Profitability & ownership
ROE56.2%
ROA34.7%
% insiders0.5%
% institutions49.2%
Last declaration on 22 April 2026
Declarations0 total
No declarations found
0 of 0 declarations
About Zealand Pharma A/S
Zealand Pharma A/S is a Danish biopharmaceutical company focused on developing treatments for metabolic and endocrine diseases. It emphasizes innovation in the field of therapeutic peptides.
